(Q38492588)

3 September 2017

title

Aliskiren reduces sympathetic nerve activity and blood pressure in chronic kidney disease patients (English)

1 reference

chronic renal insufficiency

3 September 2017

main subject

1 reference

Laima Siddiqi

1

1 reference

3 September 2017

P Liam Oey

series ordinal

2

1 reference

3 September 2017

Peter J Blankestijn

series ordinal

3

1 reference

3 September 2017

language of work or name

English

0 references

publication date

5 April 2011

1 reference

Nephrology Dialysis Transplantation

3 September 2017

published in

1 reference

3 September 2017

volume

26

1 reference

3 September 2017

issue

9

1 reference

3 September 2017

page(s)

2930-2934

1 reference

Sympathetic overactivity in patients with chronic renal failure

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ857

Sympathetic nerve activity is inappropriately increased in chronic renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ857

Sympathetic hyperactivity in chronic kidney disease: pathogenesis, clinical relevance, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ857

Is kidney ischemia the central mechanism in parallel activation of the renin and sympathetic system?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ857

Enalapril and losartan reduce sympathetic hyperactivity in patients with chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ857

Moxonidine normalizes sympathetic hyperactivity in patients with eprosartan-treated chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ857

Sympathetic activity in chronic kidney disease patients is related to left ventricular mass despite antihypertensive treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ857

Sympathetic activation in the pathogenesis of hypertension and progression of organ damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ857

Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ857

21 January 2018

Identifiers

DOI

10.1093/NDT/GFQ857

1 reference

3 September 2017

1 reference